Kura Oncology Inc (NAS:KURA)
$ 11.04 -0.13 (-1.16%) Market Cap: 858.51 Mil Enterprise Value: 419.84 Mil PE Ratio: 0 PB Ratio: 2.03 GF Score: 42/100

Kura Oncology Inc at Clinical Update Call Transcript

Nov 24, 2021 / 01:30PM GMT
Release Date Price: $14.02 (-15.54%)
Operator

Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Kura Oncology Clinical Update Conference call and Webcast. (Operator Instructions)

I would now like to hand the conference over to your speaker host today, Pete De Spain, Vice President of Investor Relations.

Pete De Spain
Kura Oncology, Inc. - VP of IR & Corporate Communications

Thank you, Olivia. Good morning, and welcome to Kura Oncology's KO-539 Clinical Update Conference Call. I'm joined on the call by Dr. Troy Wilson, our President and CEO; Dr. Marc Grasso, our CFO and CBO, is also with us and available to answer questions.

Before I turn the call over to Dr. Wilson, I would like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and may involve risks and uncertainties that could cause actual results to differ materially from expected results. Please refer to Kura's filings with the SEC, which are available from the SEC or on the Kura Oncology

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot